These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26289341)

  • 1. Exploring a new method for deriving the monetary value of a QALY.
    Tilling C; Krol M; Attema AE; Tsuchiya A; Brazier J; van Exel J; Brouwer W
    Eur J Health Econ; 2016 Sep; 17(7):801-9. PubMed ID: 26289341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating a WTP-based value of a QALY: the 'chained' approach.
    Robinson A; Gyrd-Hansen D; Bacon P; Baker R; Pennington M; Donaldson C;
    Soc Sci Med; 2013 Sep; 92():92-104. PubMed ID: 23849283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the monetary value of a QALY: a new approach based on UK data.
    Mason H; Jones-Lee M; Donaldson C
    Health Econ; 2009 Aug; 18(8):933-50. PubMed ID: 18855880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A welfare economic approach to measure outcomes in stuttering: comparing willingness to pay and quality adjusted life years.
    Franic DM; Bothe AK; Bramlett RE
    J Fluency Disord; 2012 Dec; 37(4):300-13. PubMed ID: 23218213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.
    Olofsson S; Norrlid H; Persson U
    J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness to pay for a QALY: theoretical and methodological issues.
    Gyrd-Hansen D
    Pharmacoeconomics; 2005; 23(5):423-32. PubMed ID: 15896094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the monetary value of a Quality-Adjusted Life-Year in Quebec.
    Kouakou CRC; He J; Poder TG
    Eur J Health Econ; 2024 Jul; 25(5):787-811. PubMed ID: 37656261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year.
    Attema AE; Krol M; van Exel J; Brouwer WBF
    Eur J Health Econ; 2018 Mar; 19(2):277-291. PubMed ID: 28275878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Willingness to pay for a quality-adjusted life-year: the individual perspective.
    Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
    Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trying to estimate a monetary value for the QALY.
    Pinto-Prades JL; Loomes G; Brey R
    J Health Econ; 2009 May; 28(3):553-62. PubMed ID: 19327857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment.
    van de Wetering L; van Exel J; Bobinac A; Brouwer WB
    Pharmacoeconomics; 2015 Dec; 33(12):1289-300. PubMed ID: 26232199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond QALYs: Multi-criteria based estimation of maximum willingness to pay for health technologies.
    Nord E
    Eur J Health Econ; 2018 Mar; 19(2):267-275. PubMed ID: 28258399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes.
    Donaldson C; Birch S; Gafni A
    Health Econ; 2002 Jan; 11(1):55-70. PubMed ID: 11788982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation.
    Bobinac A; van Exel NJ; Rutten FF; Brouwer WB
    J Health Econ; 2012 Jan; 31(1):158-68. PubMed ID: 22018622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life satisfaction, QALYs, and the monetary value of health.
    Huang L; Frijters P; Dalziel K; Clarke P
    Soc Sci Med; 2018 Aug; 211():131-136. PubMed ID: 29935403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of a QALY: individual willingness to pay for health gains under risk.
    Bobinac A; van Exel J; Rutten FF; Brouwer WB
    Pharmacoeconomics; 2014 Jan; 32(1):75-86. PubMed ID: 24293198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Welfare Cost of Homicides in Brazil: Accounting for Heterogeneity in the Willingness to Pay for Mortality Reductions.
    Cerqueira D; Soares RR
    Health Econ; 2016 Mar; 25(3):259-76. PubMed ID: 25523020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monetary valuation of one year in full capability and health based on demographics, health status, income and well-being.
    Thema M; Beretzky Z; Brodszky V
    Expert Rev Pharmacoecon Outcomes Res; 2024 Jun; 24(5):679-686. PubMed ID: 38656228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery.
    Gupta OP; Brown GC; Brown MM
    Am J Ophthalmol; 2008 May; 145(5):923-8. PubMed ID: 18329000
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.